Azathioprine induced hepatic veno-occlusive disease in rheumatoid arthritis.
- 1 April 1989
- journal article
- case report
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 48 (4), 342-346
- https://doi.org/10.1136/ard.48.4.342
Abstract
A patient with rheumatoid arthritis developed hepatic veno-occlusive disease following the use of azathioprine. Although azathioprine induced veno-occlusive disease is suspected to occur more frequently in patients with autoimmune dysfunction, it has not previously been reported as a complication of treatment in rheumatoid arthritis. The mechanism responsible for this condition remains unknown.This publication has 22 references indexed in Scilit:
- Azathioprine versus d‐penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with goldArthritis & Rheumatism, 1984
- Hepatic veno‐occlusive disease in a patient with systemic lupus erythematosusArthritis & Rheumatism, 1984
- Effects of aspirin and acetaminophen on the liverArchives of Internal Medicine, 1981
- Nodular Regenerative Hyperplasia of the Liver in Hematologic DisordersMedicine, 1980
- Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis.Annals Of The Rheumatic Diseases, 1980
- Fatal veno-occlusive disease of the liver following high dose chemotherapy, irradiation and bone marrow transplantationAmerican Journal Of Medicine, 1980
- Azathioprine in rheumatoid arthritisArthritis & Rheumatism, 1975
- Nodular, non-cirrhotic liver associated with portal hypertension in a patient with rheumatoid arthritisJournal of Clinical Pathology, 1974
- LIVER DISEASE IN SJÖGREN'S SYNDROME AND RHEUMATOID ARTHRITISThe Lancet, 1970
- Rheumatoid Arthritis and Polyarteritis NodosaAnnals Of The Rheumatic Diseases, 1954